Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs

Por Trigueros-Motos Laia, Pérez-Torras Sandra, Casado F, Molina-Arcas Míriam, Pastor-Anglada Marçal
Publicado em 2012-09-01

Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs

Por Pérez-Torras, Sandra, Casado, F Javier, Pastor-Anglada, Marçal
Publicado em 2012

2-Isoxazol-3-Phenyltropane Derivatives of Cocaine: Molecular and Atypical System Effects at the Dopamine Transporter

Por Hiranita, Takato, Wilkinson, Derek S., Hong, Weimin C., Zou, Mu-Fa, Kopajtic, Theresa A., Soto, Paul L., Lupica, Carl R., Newman, Amy H., Katz, Jonathan L.
Publicado em 2014

Safety and pharmacological efficiency (influence on muscular dysfunction) of new derivatives of chromon-3-aldehyde

Por A. V. Voronkov, D. I. Pozdnyakov, V. M. Rukovitsyna, E. T. Oganesyan
Publicado em 2020-08-01

The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations

Por Tallarida, Ronald J., Raffa, Robert B.
Publicado em 2010

The research of acute toxicity of 4-amino-5-(4-(tert-butyl)phenyl)-4H-1,2,4-triazoles-3-thiol derivatives

Por I. I. Аksyonova-Seliuk, Ye. S. Pruglo, O. I. Panasenko, Ye. G. Knysh
Publicado em 2017-08-01

Selection of orally active antifungal agents from 3,5-substituted isoxazolidine derivatives based on acute efficacy-safety profiles.

Por Palmer, G C, Ordy, M J, Simmons, R D, Strand, J C, Radov, L A, Mullen, G B, Kinsolving, C R, St Georgiev, V, Mitchell, J T, Allen, S D
Publicado em 1989

Low-Dose Intramuscular Dexmedetomidine as Premedication: A Randomized Controlled Trial

Por Sun, Yang, Liu, Chaolei, Zhang, Yuehong, Luo, Bin, She, Shouzhang, Xu, Lixin, Ruan, Xiangcai
Publicado no Med Sci Monit (2014)

An open-label study to estimate the effect of steady-state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal...

Por Moore, Kenneth T, Vaidyanathan, Seema, Natarajan, Jaya, Ariyawansa, Jay, Haskell, Lloyd, Turner, Kenneth C
Publicado no J Clin Pharmacol (2014)

Engineered Cell‐Derived Microparticles Bi2Se3/DOX@MPs for Imaging Guided Synergistic Photothermal/Low‐Dose Chemotherapy of Cancer

Por Dongdong Wang, Yuzhu Yao, Junkai He, Xiaoyan Zhong, Basen Li, Shiyu Rao, Haiting Yu, Shuaicheng He, Xiaoyu Feng, Tuo Xu, Bin Yang, Tuying Yong, Lu Gan, Jun Hu, Xiangliang Yang
Publicado em 2020-02-01

A comparison of three methods of setting prescribing budgets, using data derived from defined daily dose analyses of historic patterns of use.

Por Maxwell, M, Howie, J G, Pryde, C J
Publicado em 1998

Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis

Por Laurynas Mockeliunas, Lina Keutzer, Marieke G. G. Sturkenboom, Mathieu S. Bolhuis, Lotte M. G. Hulskotte, Onno W. Akkerman, Ulrika S. H. Simonsson
Publicado em 2022-03-01

Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.

Por Ledergerber, B, Bettex, J D, Joos, B, Flepp, M, Lüthy, R
Publicado em 1985

Structure-based design, synthesis, molecular docking, and biological activities of 2-(3-benzoylphenyl) propanoic acid derivatives as dual mechanism drugs

Por Ahmed, Musa A., Azam, Faizul, Rghigh, Abir M., Gbaj, Abdul, Zetrini, Abdulmottaleb E.
Publicado em 2012

The effect of a xanthine derivative, 1-(5' oxohexyl)-3-methyl-7-propylxanthine (HWA 285), on heart performance and regional blood flow in dogs and rabbits.

Por Hudlicka, O., Komarek, J., Wright, A. J.
Publicado em 1981

Association between low-dose folic acid supplementation and blood lipids concentrations in male and female subjects with atherosclerosis risk factors

Por Mierzecki, Artur, Kłoda, Karolina, Bukowska, Hanna, Chełstowski, Kornel, Makarewicz-Wujec, Magdalena, Kozłowska-Wojciechowska, Małgorzata
Publicado em 2013

Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion

Por Weersink, Rianne A, Bouma, Margriet, Burger, David M, Drenth, Joost P H, Hunfeld, Nicole G M, Kranenborg, Minke, Monster-Simons, Margje H, van Putten, Sandra A W, Metselaar, Herold J, Taxis, Katja, Borgsteede, Sander D
Publicado no BMJ Open (2016)

Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials

Por Hansen, Aaron R., Cook, Natalie, Ricci, M. Stacey, Razak, Albiruni, Le Tourneau, Christophe, McKeever, Kathleen, Roskos, Lorin, Dixit, Rakesh, Siu, Lillian L., Hinrichs, Mary Jane
Publicado no Oncologist (2015)

Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis

Por Alhusban, Ahmed, Al-Azayzih, Ahmad, Goc, Anna, Gao, Fei, Fagan, Susan C., Somanath, Payaningal R.
Publicado em 2014

Beta-carboline-3-carboxamide derivatives as promising antileishmanial agents

Por Pedroso, R B, Tonin, L T D, Ueda-Nakamura, T, Filho, B P Dias, Sarragiotto, M H, Nakamura, C V
Publicado em 2011